Tumor stiffness as an imaging biomarker of tyrosine kinase inhibitor response: A preclinical study. Luo B, Yang A, Li J, Pan C, et al. Magn Reson Imaging 2025 Nov 27:110577. doi: 10.1016/j.mri.2025.110577.

Read + Share

Amedeo Smart

Independent Medical Education

Luo B, Yang A, Li J, Pan C, et al. Tumor stiffness as an imaging biomarker of tyrosine kinase inhibitor response: A preclinical study. Magn Reson Imaging 2025 Nov 27:110577. doi: 10.1016/j.mri.2025.110577.
PMID: 41317886